Literature DB >> 14582831

Speech recognition and dysarthria: a single subject study of two individuals with profound impairment of speech and motor control.

Christina Havstam1, Margret Buchholz, Lena Hartelius.   

Abstract

This study investigated the use of the speech recognition system Dragon Dictate as an augmentative method of computer access for two individuals with cerebral palsy, including severe motor dysfunction and dysarthria. Single subject design was used and measures of computer access system effectiveness and speech production were used before, during and after intervention. The users' original switch access system was compared to a combination of their switch access system and speech recognition, by counting the number of correct entries. Adding speech recognition increased the number of correct entries by 40% for one of the participants. The other participant did not complete the intervention protocol. An independent judge rated speech production. No changes in speech were observed. Dragon Dictate is time-consuming to learn and demands a high level of motivation, but can be beneficial to a person who has profound dysarthria and great difficulties in accessing the computer.

Entities:  

Mesh:

Year:  2003        PMID: 14582831     DOI: 10.1080/14015430310015372

Source DB:  PubMed          Journal:  Logoped Phoniatr Vocol        ISSN: 1401-5439            Impact factor:   1.487


  2 in total

1.  Towards spoken clinical-question answering: evaluating and adapting automatic speech-recognition systems for spoken clinical questions.

Authors:  Feifan Liu; Gokhan Tur; Dilek Hakkani-Tür; Hong Yu
Journal:  J Am Med Inform Assoc       Date:  2011-06-24       Impact factor: 4.497

2.  A robust Kalman algorithm to facilitate human-computer interaction for people with cerebral palsy, using a new interface based on inertial sensors.

Authors:  Rafael Raya; Eduardo Rocon; Juan A Gallego; Ramón Ceres; Jose L Pons
Journal:  Sensors (Basel)       Date:  2012-03-06       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.